Developer docs
API playgroundTry for free, no card

Search company profiles

Biorad Medisys

Full company profile

uuid0000hdi

Namestring
Biorad Medisys
Legal namestring
Biorad Medisys Private Limited
Company typeenum
Private
Founded yearint
1999
Descriptiontext

Biorad Medisys Private Limited is a Pune-headquartered, founder-led Indian medical device manufacturer founded in 1999 by Mr. J.M. Hegde. The company organizes its portfolio into three wholly-owned divisions: Orthovasive (orthopedic implants for arthroplasty and sports medicine, including the GENIUS Knee System, OURO Golden Knee for nickel/chromium-allergic patients, EXCEL Medial Pivot Knee, and SIGNATURE hip systems), Neurovasive (neurovascular and peripheral vascular intervention devices including flow diverters, carotid stents, and self-expanding metal stents), and Indovasive (gastroenterology and urology endoscopy products including flexible digital ureteroscopes, Thulium Fiber Laser systems, visualization systems, and haemostatic devices). Biorad manufactures at facilities in Pune and Kolar, operates R&D in Bangalore, and maintains a registered office in Mumbai, a regional sales office in New Delhi, and international presence in the USA, UK, and Switzerland, reaching healthcare professionals and hospitals in 100+ countries.

The company generates revenue through hardware sales of these medical devices via direct field sales to healthcare institutions and a distributor network. Its go-to-market is heavily event-driven, with active participation in specialty conferences such as Arab Health, USICON, IOACON, and ISHKS. Its customer base spans orthopedic surgeons, neurovascular and interventional specialists, and gastroenterologists/urologists, with vertical segmentation by clinical specialty. Strategic positioning emphasizes motion preservation in orthopedics, minimally invasive intervention in neurovascular and endoscopy, and — via its 2025 ReShape Lifesciences asset acquisition — a clinical-stage entry into vagus nerve stimulation for diabetes and obesity management, with human trials expected within approximately one year. The company has no disclosed external venture capital or private equity ownership beyond two reported funding rounds, most recently a ~$47.89M Series 4 led by Kotak Alternate Asset Managers in May 2024.

Short descriptiontext

Biorad Medisys is a Pune-based, founder-led Indian medical device manufacturer operating through three divisions — Orthovasive (orthopedic implants), Neurovasive (neurovascular devices), and Indovasive (gastroenterology and urology endoscopy) — selling hardware to hospitals and specialists across 100+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersPune, India
HQ citystring
Pune
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
orthopedic implants, medical device manufacturing, knee replacement systems, neurovascular devices, endoscopic surgical instruments
Industry4 codes
1Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle)
CodeHLAHAEAAPrimaryYes
2Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation)
CodeHLAHAEABPrimaryNo
3Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
CodeHLAHADAAPrimaryNo
4Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
CodeHLAHAEALPrimaryNo
NAICS code3 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
  • Medical Equipment and Supplies Manufacturing3391
SIC code2 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
Product category
Orthopedic and Surgical Medical Devices
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Sales
TypeHardware Sales
Description

Manufacture and sale of orthopedic implants (knee, hip), neurovascular devices, and gastrointestinal/urology endoscopes and accessories to healthcare institutions and professionals

bioradmedisys.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 13 records shown
1OURO Golden Knee System
Description

Knee system for patients allergic to Nickel & Chromium

bioradmedisys.com
+12 more records
Core offering1 text field

Biorad Medisys manufactures and supplies medical devices across three specialized divisions: Orthovasive (orthopedic implants including knee and hip replacement systems and sports medicine devices), Neurovasive (neurovascular and peripheral vascular intervention devices such as flow diverters and carotid stents), and Indovasive (gastroenterology and urology endoscopy equipment including ureteroscopes, thulium fiber lasers, and visualization systems). The company designs, develops, and produces these implants and instruments in-house at its manufacturing facilities in Pune and Kolar, India, and distributes them globally to hospitals and healthcare professionals.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Biorad Medisys is a medical device manufacturing company organized into three strategic divisions: Orthovasive (orthopedic implants for arthroplasty and sports medicine including knee and hip systems like GENIUS, OURO Golden, EXCEL Medial Pivot, and SIGNATURE hip systems), Neurovasive (neurovascular and peripheral vascular interventions including flow diverters, carotid stents, and self-expanding metal stents), and Indovasive (gastrointestinal and urology endoscopy solutions including ureteroscopes, laser systems, visualization systems, and various endoscopic devices). The company operates across India with manufacturing facilities in Pune, Bangalore, and Kolar, and maintains global presence in the USA, UK, and Switzerland. The company has been innovating healthcare technologies since 1999 with a focus on continuous innovation and patient-centric design.

Product and service22 records
1GENIUS Knee System
CategoryOrthopedic Implants
Description

Knee replacement implant system designed for arthroplasty procedures, developed through in vivo trials starting in 2014.

2OURO Golden Knee System
CategoryOrthopedic Implants
Description

Knee implant designed specifically for patients allergic to Nickel and Chromium.

3EXCEL Medial Pivot Knee
CategoryOrthopedic Implants
Description

Medial pivot knee implant system featuring deep flexion capability for enhanced patient mobility.

4EVOCON Progressively Constrained Knee System
CategoryOrthopedic Implants
Description

Knee implant system providing progressive stability for complex arthroplasty cases.

5ROTACON Mobile Bearing Constrained Knee System
CategoryOrthopedic Implants
Description

Mobile bearing constrained knee implant system designed for improved knee mechanics.

6SIGNATURE Hip Systems
CategoryOrthopedic Implants
Description

Hip replacement implant systems including SIGNATURE NX Cup with Trabecular Titanium alloy and SIGNATURE DUO Dual Mobility System.

7SIGNATURE LRS with Antimicrobial Coating
CategoryOrthopedic Implants
Description

Limb reconstruction system with antimicrobial coating for infection prevention.

8Fixart Arthroscope
CategorySports Medicine Devices
Description

Arthroscopy device for minimally invasive joint procedures.

9GRAPNEL Unity Adjustable Loop Cortical Fixation Implant
CategorySports Medicine Devices
Description

Adjustable loop fixation device for soft tissue repair in sports medicine and orthopedic procedures.

10QUANTINO Thulium Fiber Laser System
CategoryUrology Endoscopy Devices
Description

Thulium fiber laser technology system for urological procedures including lithotripsy.

11Enli8 Visualisation System
CategoryEndoscopy Visualization
Description

Visualization system for urology and gastroenterology endoscopic procedures.

12GLITZ Direct In-Scope Suction Device
CategoryUrology Endoscopy Devices
Description

Direct In-scope Suction (DISS) device for RIRS (Retrograde Intrarenal Surgery) technique.

13Cholangioscope
CategoryGastroenterology Endoscopy Devices
Description

Endoscopic device for ERCP (Endoscopic Retrograde Cholangiopancreatography) procedures.

14KLOSURE Haemorrhoid Closure Device
CategoryGastroenterology Endoscopy Devices
Description

Haemorrhoid treatment device with band counters and suction functionality.

15BIOQLOT Instant Endoscopic Haemostatic Spray
CategoryGastroenterology Endoscopy Devices
Description

Endoscopic haemostatic spray for immediate bleeding control during GI procedures.

16LITHOFRAG Mechanical Lithotripter
CategoryGastroenterology Endoscopy Devices
Description

Mechanical lithotripter for emergency removal of gall stones during endoscopic procedures.

17EVOLVIA Self-Expanding Metal Stents
CategoryNeurovascular and GI Stents
Description

Self-expanding metal stents for various hollow organ obstructions.

18Flow Diverter
CategoryNeurovascular Devices
Description

Kink-resistant braided metal stent for intracranial aneurysm treatment.

19Carotid Stent
CategoryNeurovascular Devices
Description

Laser-cut Nitinol stent for carotid artery interventions.

20ASD Atrial Septal Device
CategoryCardiac Intervention Devices
Description

Closure device for atrial septal defects.

21Indoscope-Urs Flexible Digital Ureteroscope
CategoryUrology Endoscopy Devices
Description

Flexible digital ureteroscope for minimally invasive urology procedures.

22INDUS Knee System
CategoryOrthopedic Implants
Description

Knee replacement implant system whose manufacturing rights were acquired in 2008.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2026-01-05
Description

iMDx partnered with Bio-Rad to support commercial-scale manufacturing of GraftAssureDx test kit. Bio-Rad provides manufacturing capabilities for iMDx's kidney transplant rejection diagnostic product.

2Frid Mind Technologies (FMT)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-16
Description

Biorad Medisys invested in Frid Mind Technologies (FMT) in Belgium to enhance offerings in stroke prevention and rehabilitation technologies as part of their Neurovasive division expansion.

thehindubusinessline.com
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-10-16
Description

Biorad Medisys acquired a stake in Motion Informatics Ltd in Israel to strengthen their neurovascular and peripheral vascular portfolio with advanced stroke prevention and rehabilitation technologies.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-06-26
Description

Biorad Medisys acquired assets from ReShape Lifesciences, including vagus nerve stimulation (VNS) technology for diabetes management. This acquisition supports the development of an implantable VNS device for managing blood-glucose levels, improving insulin sensitivity, and aiding in obesity management. Animal trials have been completed with human trials expected to begin by end of next year.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-06-26
Description

ReShape Lifesciences announced a merger with Vyome Therapeutics, with Biorad Medisys involved through the asset purchase agreement.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

India-based medical device company with strong orthopedic, cardiovascular, and surgical portfolios; the closest Indian peer to Biorad's three-division medtech platform.

TypeDirect peer
Description

Specialist in neurovascular and peripheral vascular intervention including flow diverters and stroke thrombectomy — directly comparable to Biorad's Neurovasive division and Flow Diverter product.

TypeBroad incumbent
Description

Global leader in orthopedic joint reconstruction (knee, hip) — directly comparable to Biorad's Orthovasive division with the GENIUS, OURO, EXCEL, and SIGNATURE product lines, but at vastly larger scale.

TypeBroad incumbent
Description

Multi-specialty medical device leader with significant orthopedic (knees, hips, trauma) and surgical instruments portfolios that overlap with Biorad's orthopedic and endoscopy offerings.

TypeBroad incumbent
Description

Global orthopedics, sports medicine, and advanced wound management company — directly comparable to Biorad's arthroplasty and sports medicine lines including GRAPNEL and SIGNATURE systems.

TypeBroad incumbent
Description

Diversified medical device leader with major neurovascular (aneurysm, stroke), orthopedic, and surgical portfolios — competes with Biorad across multiple divisions at global scale.

TypeBroad incumbent
Description

Global medtech with significant peripheral vascular, neurovascular, and endoscopy franchises — directly comparable to Biorad's Neurovasive and Indovasive GI/urology endoscopy portfolios.

TypeBroad incumbent
Description

Global leader in GI and urology endoscopy systems, flexible ureteroscopes, and visualization — directly comparable to Biorad's Indovasive division including Indoscope-Urs and Enli8 visualization.

TypeDirect peer
Description

Mid-cap medical device company with orthopedic, general surgery, and GI/endoscopy portfolios that overlap with Biorad's sports medicine, arthroscopy, and GI divisions.

TypeEmerging player
Description

Emerging medical device player with growing orthopedics and surgical adjacencies; comparable as a non-incumbent scaling multi-specialty medtech platform.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biorad Medisys

Orthopedic and Surgical Medical Devicesbioradmedisys.com

Biorad Medisys is a Pune-based, founder-led Indian medical device manufacturer operating through three divisions — Orthovasive (orthopedic implants), Neurovasive (neurovascular devices), and Indovasive (gastroenterology and urology endoscopy) — selling hardware to hospitals and specialists across 100+ countries.

What Biorad Medisys does

Biorad Medisys Private Limited is a Pune-headquartered, founder-led Indian medical device manufacturer founded in 1999 by Mr. J.M. Hegde. The company organizes its portfolio into three wholly-owned divisions: Orthovasive (orthopedic implants for arthroplasty and sports medicine, including the GENIUS Knee System, OURO Golden Knee for nickel/chromium-allergic patients, EXCEL Medial Pivot Knee, and SIGNATURE hip systems), Neurovasive (neurovascular and peripheral vascular intervention devices including flow diverters, carotid stents, and self-expanding metal stents), and Indovasive (gastroenterology and urology endoscopy products including flexible digital ureteroscopes, Thulium Fiber Laser systems, visualization systems, and haemostatic devices). Biorad manufactures at facilities in Pune and Kolar, operates R&D in Bangalore, and maintains a registered office in Mumbai, a regional sales office in New Delhi, and international presence in the USA, UK, and Switzerland, reaching healthcare professionals and hospitals in 100+ countries.

The company generates revenue through hardware sales of these medical devices via direct field sales to healthcare institutions and a distributor network. Its go-to-market is heavily event-driven, with active participation in specialty conferences such as Arab Health, USICON, IOACON, and ISHKS. Its customer base spans orthopedic surgeons, neurovascular and interventional specialists, and gastroenterologists/urologists, with vertical segmentation by clinical specialty. Strategic positioning emphasizes motion preservation in orthopedics, minimally invasive intervention in neurovascular and endoscopy, and — via its 2025 ReShape Lifesciences asset acquisition — a clinical-stage entry into vagus nerve stimulation for diabetes and obesity management, with human trials expected within approximately one year. The company has no disclosed external venture capital or private equity ownership beyond two reported funding rounds, most recently a ~$47.89M Series 4 led by Kotak Alternate Asset Managers in May 2024.

Biorad Medisys firmographics

Firmographics
Name
Biorad Medisys
Legal name
Biorad Medisys Private Limited
Website
https://bioradmedisys.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Biorad Medisys is a Pune-based, founder-led Indian medical device manufacturer operating through three divisions — Orthovasive (orthopedic implants), Neurovasive (neurovascular devices), and Indovasive (gastroenterology and urology endoscopy) — selling hardware to hospitals and specialists across 100+ countries.
Ownership category
akta.pro rank

Biorad Medisys industry classification

Industry
Product category
Orthopedic and Surgical Medical Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)
akta.pro secondary industries
Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB), Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA), Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL)

Keywords

  • Orthopedic implants
  • Medical device manufacturing
  • Knee replacement systems
  • Neurovascular devices
  • Endoscopic surgical instruments

Where Biorad Medisys is headquartered

Location

Headquarters

HQ city
Pune
HQ country
India
HQ region
Asia

Offices5 records

Markets served

Biorad Medisys business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Device Sales: Manufacture and sale of orthopedic implants (knee, hip), neurovascular devices, and gastrointestinal/urology endoscopes and accessories to healthcare institutions and professionals

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Biorad Medisys product offering

Product offering

Core offering

Biorad Medisys manufactures and supplies medical devices across three specialized divisions: Orthovasive (orthopedic implants including knee and hip replacement systems and sports medicine devices), Neurovasive (neurovascular and peripheral vascular intervention devices such as flow diverters and carotid stents), and Indovasive (gastroenterology and urology endoscopy equipment including ureteroscopes, thulium fiber lasers, and visualization systems). The company designs, develops, and produces these implants and instruments in-house at its manufacturing facilities in Pune and Kolar, India, and distributes them globally to hospitals and healthcare professionals.

Product overview

Biorad Medisys is a medical device manufacturing company organized into three strategic divisions: Orthovasive (orthopedic implants for arthroplasty and sports medicine including knee and hip systems like GENIUS, OURO Golden, EXCEL Medial Pivot, and SIGNATURE hip systems), Neurovasive (neurovascular and peripheral vascular interventions including flow diverters, carotid stents, and self-expanding metal stents), and Indovasive (gastrointestinal and urology endoscopy solutions including ureteroscopes, laser systems, visualization systems, and various endoscopic devices). The company operates across India with manufacturing facilities in Pune, Bangalore, and Kolar, and maintains global presence in the USA, UK, and Switzerland. The company has been innovating healthcare technologies since 1999 with a focus on continuous innovation and patient-centric design.

Differentiator

Problem solved

Functional benefit

Brands

  • OURO Golden Knee System: Knee system for patients allergic to Nickel & Chromium
  • SIGNATURE Nx Trabecular Titanium Alloy
  • SIGNATURE DUO Dual Mobility System
  • EXCEL Medial Pivot Knee
  • GENIUS Knee System
  • EVOCON Progressively Constrained Knee System
  • ROTACON Mobile Bearing Constrained Knee System
  • Indoscope-Urs
  • QUANTINO Thulium Fiber Laser System
  • Enli8 Visualisation System
  • GLITZ
  • EVOLVIA
  • Flow Diverter

Products and services

  • GENIUS Knee System Knee replacement implant system designed for arthroplasty procedures, developed through in vivo trials starting in 2014.
  • OURO Golden Knee System Knee implant designed specifically for patients allergic to Nickel and Chromium.
  • EXCEL Medial Pivot Knee Medial pivot knee implant system featuring deep flexion capability for enhanced patient mobility.
  • EVOCON Progressively Constrained Knee System Knee implant system providing progressive stability for complex arthroplasty cases.
  • ROTACON Mobile Bearing Constrained Knee System Mobile bearing constrained knee implant system designed for improved knee mechanics.
  • SIGNATURE Hip Systems Hip replacement implant systems including SIGNATURE NX Cup with Trabecular Titanium alloy and SIGNATURE DUO Dual Mobility System.
  • SIGNATURE LRS with Antimicrobial Coating Limb reconstruction system with antimicrobial coating for infection prevention.
  • Fixart Arthroscope Arthroscopy device for minimally invasive joint procedures.
  • GRAPNEL Unity Adjustable Loop Cortical Fixation Implant Adjustable loop fixation device for soft tissue repair in sports medicine and orthopedic procedures.
  • QUANTINO Thulium Fiber Laser System Thulium fiber laser technology system for urological procedures including lithotripsy.
  • Enli8 Visualisation System Visualization system for urology and gastroenterology endoscopic procedures.
  • GLITZ Direct In-Scope Suction Device Direct In-scope Suction (DISS) device for RIRS (Retrograde Intrarenal Surgery) technique.
  • Cholangioscope Endoscopic device for ERCP (Endoscopic Retrograde Cholangiopancreatography) procedures.
  • KLOSURE Haemorrhoid Closure Device Haemorrhoid treatment device with band counters and suction functionality.
  • BIOQLOT Instant Endoscopic Haemostatic Spray Endoscopic haemostatic spray for immediate bleeding control during GI procedures.
  • LITHOFRAG Mechanical Lithotripter Mechanical lithotripter for emergency removal of gall stones during endoscopic procedures.
  • EVOLVIA Self-Expanding Metal Stents Self-expanding metal stents for various hollow organ obstructions.
  • Flow Diverter Kink-resistant braided metal stent for intracranial aneurysm treatment.
  • Carotid Stent Laser-cut Nitinol stent for carotid artery interventions.
  • ASD Atrial Septal Device Closure device for atrial septal defects.
  • Indoscope-Urs Flexible Digital Ureteroscope Flexible digital ureteroscope for minimally invasive urology procedures.
  • INDUS Knee System Knee replacement implant system whose manufacturing rights were acquired in 2008.

Companies that use Biorad Medisys

Customer profile

Segments3 records

Ideal customer profiles3 records

Biorad Medisys technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

Biorad Medisys partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • Bio-RadcoreOEM/ Whitelabel/ Licensing Partner · 5 January 2026iMDx partnered with Bio-Rad to support commercial-scale manufacturing of GraftAssureDx test kit. Bio-Rad provides manufacturing capabilities for iMDx's kidney transplant rejection diagnostic product.
  • Frid Mind Technologies (FMT)coreStrategic or Co-development Partner · 16 October 2025Biorad Medisys invested in Frid Mind Technologies (FMT) in Belgium to enhance offerings in stroke prevention and rehabilitation technologies as part of their Neurovasive division expansion.
  • Motion Informatics LtdcoreTechnology or Integration · 16 October 2025Biorad Medisys acquired a stake in Motion Informatics Ltd in Israel to strengthen their neurovascular and peripheral vascular portfolio with advanced stroke prevention and rehabilitation technologies.
  • ReShape LifesciencescoreStrategic or Co-development Partner · 26 June 2025Biorad Medisys acquired assets from ReShape Lifesciences, including vagus nerve stimulation (VNS) technology for diabetes management. This acquisition supports the development of an implantable VNS device for managing blood-glucose levels, improving insulin sensitivity, and aiding in obesity management. Animal trials have been completed with human trials expected to begin by end of next year.
  • Vyome TherapeuticsminorStrategic or Co-development Partner · 26 June 2025ReShape Lifesciences announced a merger with Vyome Therapeutics, with Biorad Medisys involved through the asset purchase agreement.

Scale indicators2 records

Recent moves9 records

Expansion highlights5 records

Biorad Medisys competitors and assessment

Company assessment

Direct peers

  • Meril Life Sciences: India-based medical device company with strong orthopedic, cardiovascular, and surgical portfolios; the closest Indian peer to Biorad's three-division medtech platform.
  • Penumbra: Specialist in neurovascular and peripheral vascular intervention including flow diverters and stroke thrombectomy — directly comparable to Biorad's Neurovasive division and Flow Diverter product.
  • Conmed Corporation: Mid-cap medical device company with orthopedic, general surgery, and GI/endoscopy portfolios that overlap with Biorad's sports medicine, arthroscopy, and GI divisions.

Broad incumbents

  • Zimmer Biomet: Global leader in orthopedic joint reconstruction (knee, hip) — directly comparable to Biorad's Orthovasive division with the GENIUS, OURO, EXCEL, and SIGNATURE product lines, but at vastly larger scale.
  • Stryker: Multi-specialty medical device leader with significant orthopedic (knees, hips, trauma) and surgical instruments portfolios that overlap with Biorad's orthopedic and endoscopy offerings.
  • Smith & Nephew: Global orthopedics, sports medicine, and advanced wound management company — directly comparable to Biorad's arthroplasty and sports medicine lines including GRAPNEL and SIGNATURE systems.
  • Medtronic: Diversified medical device leader with major neurovascular (aneurysm, stroke), orthopedic, and surgical portfolios — competes with Biorad across multiple divisions at global scale.
  • Boston Scientific: Global medtech with significant peripheral vascular, neurovascular, and endoscopy franchises — directly comparable to Biorad's Neurovasive and Indovasive GI/urology endoscopy portfolios.
  • Olympus Corporation: Global leader in GI and urology endoscopy systems, flexible ureteroscopes, and visualization — directly comparable to Biorad's Indovasive division including Indoscope-Urs and Enli8 visualization.

Emerging players

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Biorad Medisys social profiles

Digital presence

Biorad Medisys financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biorad Medisys leadership team

Management profile

Number of profiles

Profiles5 records

Biorad Medisys subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

Biorad Medisys funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biorad Medisys M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biorad Medisys

What does Biorad Medisys do?

Biorad Medisys manufactures and supplies medical devices across three specialized divisions: Orthovasive (orthopedic implants including knee and hip replacement systems and sports medicine devices), Neurovasive (neurovascular and peripheral vascular intervention devices such as flow diverters and carotid stents), and Indovasive (gastroenterology and urology endoscopy equipment including ureteroscopes, thulium fiber lasers, and visualization systems). The company designs, develops, and produces these implants and instruments in-house at its manufacturing facilities in Pune and Kolar, India, and distributes them globally to hospitals and healthcare professionals.

Is Biorad Medisys a public or private company?

Biorad Medisys is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Biorad Medisys founded?

Biorad Medisys was founded in 1999. It employs 1,001 to 5,000 people.

Where is Biorad Medisys based?

Biorad Medisys is headquartered in Pune, India, in the Asia region.

How does Biorad Medisys make money?

One revenue line is on record: medical Device Sales.

Who are Biorad Medisys's main competitors?

Direct peers on record are Meril Life Sciences, Penumbra and Conmed Corporation. Broad incumbents are Zimmer Biomet, Stryker, Smith & Nephew, Medtronic, Boston Scientific and Olympus Corporation. PolyNovo (or Sterimed/Steris Surgical) is listed as an emerging player.

Does Biorad Medisys have an API?

No public API is recorded for Biorad Medisys.

What industry is Biorad Medisys in?

Biorad Medisys's product category is Orthopedic and Surgical Medical Devices. Its primary akta.pro industry code is HLAHAEAA, Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle), with a secondary code of HLAHAEAB, Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Medical BuyerBiorad Medisys to raise Rs 400 crore in pre-IPO roundBiorad Medisys is raising approximately ₹400 crore in a pre-IPO private funding round, with the transaction expected to value the company at around ₹10,000 crore, according to two people familiar with the matter. The company has engaged Grant Thornton as advisor for the private deal and separately appointed CLSA India, ICICI Securities, and Nuvama to advise on a planned IPO targeting at least ₹1,500 crore and a ₹12,000 crore valuation. The fundraising follows prior rounds including ₹400 crore raised from Kotak Strategic Situations India Fund II in 2024, and comes as India's medical devices sector is projected to grow at a 16.4% CAGR to reach $50 billion over the next five years.The Times of IndiaAs issues line up, many companies join pre-IPO placement queue - The Economic TimesPre-IPO placements are making a comeback in India after a subdued start to 2026, with companies securing valuations and marquee investors before their public offerings. Three companies have already raised funds in July, including Karamtara Engineering (₹75 crore), Biorad Medisys (₹400 crore), and Silver Consumer Electricals (₹150 crore), while at least four more including SBI Funds Management (₹2,000 crore planned) and Neuberg Diagnostics (₹500 crore planned) are preparing placements. The revival follows a sharp decline from the December 2025 peak of ₹20,412 crore in pre-IPO activity to just ₹565 crore in the June quarter.MintKotak-backed Biorad Medisys in talks to raise ₹400 crore ahead of a potential IPO | Company Business NewsBiorad Medisys, a Kotak-backed medical devices manufacturer, is raising approximately ₹400 crore in a pre-IPO private funding round at a valuation of around ₹10,000 crore, with Grant Thornton appointed as advisor for the transaction.Business StandardBiorad Medisys works on 'pacemaker' for managing diabetes with VNS techBiorad Medisys, a Pune-based medical-device manufacturer, is developing an implantable vagus nerve stimulation (VNS) device positioned as a \"pacemaker for diabetes\" to manage blood-glucose levels, improve insulin sensitivity, and reduce obesity. The company has completed animal trials in Australia and plans to begin human trials in India by end of next year, with estimated trial costs of $5–6 million. Biorad Medisys acquired ReShape Lifesciences\' assets through an asset-purchase agreement linked to the ReShape–Vyome Therapeutics merger, entering the US market via a new subsidiary, Medtimo Inc.www.passionateinmarketing.comBiorad Medisys Invests in Stroke and Vascular SolutionsBiorad Medisys Pvt. Ltd., a Pune-based medical devices company, has invested in Frid Mind Technologies (FMT), a Belgium-based company that developed a patented stroke-prevention product using advanced braiding technology, which has completed preclinical trials and two first-in-human cases with positive follow-up. Separately, Biorad acquired a 10% stake in Motion Informatics Ltd., an Israel-based company that manufactures the US FDA-approved Stimel-03 stroke rehabilitation device, for which Biorad holds manufacturing and distribution rights in select geographies including India and the United States. These collaborations in neurovascular and peripheral vascular markets align with Biorad's stated efforts in vascular and stroke care.Med-Tech InsightsMedtimo files patent infringement complaint against Allurion TechnologiesMedtimo Inc., a wholly owned subsidiary of Biorad Medisys Private Limited, has filed a patent infringement complaint in the U.S. District Court of Delaware against Allurion Technologies, alleging that Allurion's gastric balloon system infringes three of Medtimo's patents. The complaint is a refiling of a 2023 lawsuit with two additional patents that were awarded by the USPTO in 2023 and 2024, following Allurion's unsuccessful challenge of Medtimo's patent rights. Medtimo's CEO stated the company is fully prepared to vigorously protect its intellectual property and the significant investments made in research and development.GlobeNewswireBiorad Medisys announces its entry into the US market with the launch of its new subsidiary Medtimo Inc.Biorad Medisys launched its US subsidiary Medtimo Inc. after acquiring ReShape Lifesciences assets and rebranding. The company will focus on Lap-Band and Stimel-03, with accelerated FDA-approved Obalon balloon manufacturing. The move aims to expand in obesity and neurological rehabilitation markets.GlobeNewswireReShape Lifesciences® Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Therapeutics and Asset Purchase Agreement with Biorad MedisysReShape Lifesciences announced a workforce reduction estimated to save over $750,000 annually, or 23.4% of payroll expenses. The company also updated on its merger with Vyome Therapeutics and asset sale to Biorad Medisys, with a shareholder vote scheduled for July 24, 2025.FinvizReShape Lifesciences Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Therapeutics and Asset Purchase Agreement with Biorad MedisysReShape Lifesciences announced a strategic workforce reduction expected to save over $750,000 annually while providing an update on its pending merger with Vyome Therapeutics and asset sale to Biorad Medisys. The company has scheduled a special shareholder meeting for July 24, 2025, to vote on these transactions, which have received unanimous board endorsement. This restructuring aims to improve operational efficiency as ReShape continues to promote its Lap-Band products and expand internationally.GlobeNewswireReShape Lifesciences® Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Therapeutics and Asset Purchase Agreement with Biorad MedisysReShape Lifesciences announced strategic workforce reductions expected to generate annualized savings of over $750,000, representing approximately 23.4% of annual payroll expenses, while preserving its sales and marketing team. The company also provided updates on two pending transactions: a merger agreement with Vyome Therapeutics and an asset purchase agreement with Biorad Medisys, with a special shareholder meeting to vote on these transactions scheduled for July 24, 2025. The Board of Directors has unanimously endorsed these transactions as a transformative opportunity to unlock long-term shareholder value and accelerate growth.